Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516199 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Life Sciences Industry IT Spending Forecast in the US through 2014

Datamonitor, Feb 2010, Pages: 22


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

As pharmaceutical and biotechnology companies increasingly turn to IT to reduce costs and the time-to-market of a drug, it is important for technology vendors to understand where growth opportunities exist in the global life science market. This Databook provides a forecast and analysis of IT spending in the pharma/biotech industries through to 2014.

Scope

- Forecast of IT spending within the the US pharmaceutical and biotechnology markets by sector, and IT segments (hardware, software, services)

- Sectors covered are Big Pharma, Mid Pharma, Big Biotech, and Small Pharma & Biotech

Highlights of this title

Although the current economic climate and credit crunch has halted major IT projects for a couple of years, technology investments will continue to grow on a worldwide basis over the next five years, particularly in the biotechnology sector which is becoming a core area of research for future drugs.

Big Pharma will spend the highest amount of money on IT as they are turning to technology solutions to increase efficiencies within the drug lifecycle, reduce costs, and bring the drug to market faster, but the overall CAGR will be the lowest of the four sectors.

Once companies have the appropriate hardware technologies in place, they will begin to spend a larger portion of their budget on software and services.

Key reasons to purchase this title

- Understand the opportunity size for technology spending in the life sciences industry

- Identify potential areas for spending growth amongst pharmaceutical and biotechnology companies

- Segment the life science industry by spending opportunities




Customers who bought this item also bought

Life Sciences Industry IT Spending Forecast in Canada through 2014

Life Sciences Industry IT Spending Forecast in Mexico through 2014

Life Sciences Industry IT Spending Forecast in Argentina through 2014

Life Sciences Industry IT Spending Forecast in Brazil through 2014

Life Sciences Industry IT Spending Forecast in South Korea through 2014

Life Sciences Industry IT Spending Forecast in France through 2014

Life Sciences Industry IT Spending Forecast in India through 2014

Life Sciences Industry IT Spending Forecast in Italy through 2014

Life Sciences Industry IT Spending Forecast in Australia through 2014

Life Sciences Industry IT Spending Forecast in Japan through 2014



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds